Overview

A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches

Status:
Completed

Trial end date:
2011-08-01

Target enrollment:

Participant gender:

Summary

This study is being conducted to evaluate the efficacy of a 91-day extended cycle oral contraceptive compared to placebo for decreasing the frequency and severity of menstrually-related migraine headaches.

Phase:

Phase 2

Details

Lead Sponsor:

Duramed Research

Treatments:

Contraceptive Agents
Contraceptives, Oral
Levonorgestrel